Cerebellum Organoid Modeling Service
Our Cerebellum Organoid Modeling Service provides advanced 3D human cerebellar organoids (hCerOs) derived from patient-specific iPSCs or engineered cell lines. Utilizing CRISPR-Cas9 and optimized protocols, Creative Biolabs generates organoids with functional Purkinje cells, granular neurons, and human-specific developmental features. These models enable precise study of cerebellar disorders, drug testing, and mechanistic research, bridging the gap between in vitro and in vivo neuroscience. Our platform accelerates breakthroughs in understanding and treating ataxias, autism, and brain cancers.
Introduction
The cerebellum, a vital brain region, plays crucial roles in motor coordination, cognitive functions, and emotional processing. Dysfunction in cerebellar development or activity is strongly linked to neurological disorders such as spinocerebellar ataxia (SCA), autism spectrum disorders, and medulloblastoma. Traditional research models, including animal studies, often fall short in replicating human-specific cerebellar characteristics, such as neuronal subtype ratios and the complexity of its folded structure (foliation). This limitation hinders their translational relevance.
Recent breakthroughs in cerebellar organoid technology have revolutionized the study of human cerebellar biology and disease. By utilizing human induced pluripotent stem cells (iPSCs), researchers have developed three-dimensional human cerebellar organoids (hCerOs) that closely mimic fetal cerebellar development, including the generation of functional Purkinje cells – the primary output neurons of the cerebellar cortex. These hCerOs replicate the cellular diversity, layered organization, and functional neural networks observed in vivo, offering unprecedented opportunities to model diseases, screen therapeutics, and investigate human-specific neurodevelopmental mechanisms.
At Creative Biolabs, we integrate cutting-edge protocols to provide researchers with robust, physiologically relevant tools for advancing cerebellar research.
Key Advantages
- Mirroring Human Cerebellar Complexity: Diverse Cell Populations
Our hCerOs faithfully replicate the intricate cellular composition of the developing human cerebellum, generating all major cell types, including granule cell precursors, Purkinje neurons, and human-specific rhombic lip-derived progenitors. This cellular diversity closely reflects in vivo developmental stages, enabling in-depth studies of cell-type-specific mechanisms and interspecies differences. Unlike traditional models, our organoids capture unique human cerebellar features, such as distinct neuronal subtype ratios and structural complexity, making them ideal for investigating neurodevelopmental disorders and evolutionary distinctions.
- Recreating Native Architecture: Structured Organization
Our hCerOs self-organize into spatially distinct ventricular and rhombic lip progenitor zones, closely resembling the layered organization of the fetal cerebellum. Through optimized culture conditions, we achieve patterning reminiscent of the external granular layer (EGL) and Purkinje cell layer (PCL), which are critical for studying neuronal migration and circuit formation. This structural fidelity ensures that crucial cellular interactions and microenvironmental cues are preserved, providing a physiologically relevant system for disease modeling and drug screening.
- Capturing Functional Activity: Maturation and Network Integration
Long-term cultured hCerOs develop synchronized neuronal networks exhibiting spontaneous calcium oscillations and action potential firing, indicating functional synaptic connectivity. Our platform supports advanced electrophysiological studies and optogenetic manipulation, allowing real-time interrogation of cerebellar circuitry. These functional networks provide a dynamic model to explore neurotoxicity, circuit dysfunction in cerebellar ataxias, and the impact of genetic mutations on neuronal activity.
Our Comprehensive Cerebellum Organoid Services
We offer end-to-end solutions for generating, characterizing, and applying cerebellar organoids in both research and drug development:
1. Customized hCerO Generation
- Differentiation of iPSCs/ESCs into cerebellar organoids using optimized protocols.
- Incorporation of human-specific morphogens (e.g., FGF8b, SDF1α) to enhance rhombic lip and ventricular zone patterning.
2. Precise Disease Modeling
- Development of patient-derived organoids for hereditary ataxias, medulloblastoma, and neurodevelopmental disorders.
- CRISPR-Cas9-mediated gene editing to introduce or correct disease-associated mutations (e.g., ATXN3 CAG repeat expansion).
3. Advanced Drug Screening & Toxicity Testing
- High-throughput platforms to evaluate neuroprotective compounds, small molecules, or gene therapies.
- Functional readouts including calcium imaging, electrophysiology, and apoptosis assays.
4. In-Depth Characterization
- Immunohistochemistry for key markers like ATOH1 (granule cells), CALB1 (Purkinje cells), and BARHL1 (progenitors).
- Electrophysiological analysis of Purkinje cell activity and network synchronization.
5. Long-Term Maturation & Co-Culture Systems
- Extended culturing (up to 8 months) to achieve advanced neuronal maturation.
- Integration with organoids from other brain regions (e.g., cortical or midbrain) to study cerebellar connectivity.
Our Workflow
Partner with Us to Advance Your Cerebellar Research
Leverage our expertise in cutting-edge cerebellar organoid technology to accelerate your research into brain development, disease mechanisms, and therapeutic discovery. Contact us today to design a tailored solution for your project.
Reference
- Ryu, Seungmi et al. “Modeling Friedreich's ataxia with Bergmann glia-enriched human cerebellar organoids.” bioRxiv : the preprint server for biology 2025.05.16.654315. 16 May. 2025, doi:10.1101/2025.05.16.654315. Preprint. Distributed under Open Access License CC0. The original image was modified.
- iNeuMab™ Rabbit Anti-Alpha-synuclein (CBP1631) (Cat#: NAB-08-PZ079)
- iNeuMab™ Mouse Anti-EFNB2 Monoclonal Antibody (CBP1159) (Cat#: NAB-0720-Z4396)
- iNeuMab™ Mouse Anti-LRP1 Monoclonal Antibody (CBP3363) (Cat#: NAB-0720-Z6479)
- Mouse Anti-Human α-Synuclein Phospho (Tyr39) (CBP3706) (Cat#: NAB201250LS)
- Mouse Anti-SCN5A Monoclonal Antibody (CBP708) (Cat#: NAB-0720-Z2720)
- iNeuMab™ Rabbit Anti-LRRK2 Monoclonal Antibody (CBP1887) (Cat#: NAB-08-PZ735)
- iNeuMab™ Mouse Anti-SHANK3 Monoclonal Antibody (CBP929) (Cat#: NAB-0720-Z3477)
- iNeuMab™ Anti-F-Spondin/SPON1 Antibody, Clone 3F4 (Cat#: NRZP-0822-ZP4740)
- Human Brain Astroblastoma U-87 MG (Cat#: NCL2110P117)
- Green Fluorescent Alpha-synuclein Cell Line (Cat#: NCL2110P209)
- Human Brain Vascular Adventitial Fibroblasts (Cat#: NCL-21P6-014)
- Human Astrocytes, Immortalized (Cat#: NCL-2105-P182-AM)
- Rat Glioma Cell Line C6 (Cat#: NCL2110P346)
- Mouse Glioma Cell Line GL-261-Luc (Cat#: NCL-2108P06)
- Human Microglia Cell Line HMC3, Immortalized (Cat#: NCL-2108P38)
- Human Astrocytes (Cat#: NCC20-9PZ01)
- Rat Olfactory Ensheathing Cells (Cat#: NRZP-1122-ZP162)
- Immortalized Human Cerebral Microvascular Endothelial Cells (Cat#: NCL-2108-P020)
- Human GFAP ELISA Kit [Colorimetric] (Cat#: NPP2011ZP383)
- Alpha Synuclein Aggregation Kit (Cat#: NRZP-1122-ZP15)
- Beta Amyloid (1-40), Aggregation Kit (Cat#: NRZP-0323-ZP199)
- Amyloid beta 1-42 Kit (Cat#: NRP-0322-P2170)
- Human Tau Aggregation Kit (Cat#: NRP-0322-P2173)
- Alpha-Synuclein Aggregation Assay Kit (Cat#: NRZP-1122-ZP37)
- Human Poly ADP ribose polymerase,PARP Assay Kit (Cat#: NRZP-1122-ZP62)
- Beta Amyloid (1-42), Aggregation Kit (Cat#: NRZP-0323-ZP200)
- VSV-eGFP (Cat#: NTA-2011-ZP20)
- AAV2 Full Capsids, Reference Standards (Cat#: NTC2101070CR)
- Dextran, NHS Activated (Cat#: NRZP-0722-ZP124)
- Human superoxide dismutase 1, soluble (SOD1) (NM_000454) ORF clone, TurboGFP Tagged (Cat#: NEP-0521-R0748)
- Rat Parkinson disease (autosomal recessive, juvenile) 2, parkin (Park2) (NM_020093) ORF clone/lentiviral particle, Myc-DDK Tagged (Cat#: NEP-0621-R0041)
- Human superoxide dismutase 3, extracellular (SOD3) (NM_003102) ORF clone, Untagged (Cat#: NEP-0521-R0808)
- Mouse SOD1 shRNA Silencing Adenovirus (Cat#: NV-2106-P14)
- Lenti of Human TAR DNA binding protein (TARDBP) (NM_007375) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0832)
- Lenti of Mouse synuclein, alpha (Snca) transcript variant (NM_001042451) ORF clone, mGFP Tagged (Cat#: NEP-0521-R0864)
- App Rat amyloid beta (A4) precursor protein (App)(NM_019288) ORF clone, Untagged (Cat#: NEP-0421-R0053)
- Human huntingtin-associated protein 1 (HAP1) transcript variant 2 (NM_177977) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0676)
- Human huntingtin (HTT) (NM_002111) ORF clone, Myc-DDK Tagged (Cat#: NEP-0521-R0497)
- Human apolipoprotein E (APOE) (NM_000041) ORF clone, Untagged (Cat#: NEP-0421-R0232)
- NeuroBiologics™ Mouse Cerebrospinal Fluid (Cat#: NRZP-0822-ZP497)
- NeuroBiologics™ Rat Cerebrospinal Fluid (Cat#: NRZP-0822-ZP496)
- NeuroBiologics™ Pig Cerebrospinal Fluid (Cat#: NRZP-0822-ZP498)
- NeuroBiologics™ Human Cerebrospinal Fluid (Cat#: NRZP-0822-ZP491)
- NeuroBiologics™ Monkey Cerebrospinal Fluid (Cat#: NRZP-0822-ZP495)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP501)
- NeuroPro™ Anti-EPO BBB Shuttle Protein (Cat#: NRZP-0423-ZP508)
- NeuroPro™ Anti-PON1 BBB Shuttle Protein (Cat#: NRZP-0423-ZP507)
- NeuroPro™ Anti-idursulfase BBB Shuttle Protein (Cat#: NRZP-0423-ZP497)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP502)
- NeuroPro™ Anti-IDUA BBB Shuttle Protein (Cat#: NRZP-0423-ZP498)
- NeuroPro™ Anti-TNFR BBB Shuttle Protein (Cat#: NRZP-0423-ZP510)
- NeuroPro™ Anti-Erythropoietin BBB Shuttle Protein (Cat#: NRZP-0423-ZP499)
- NeuroPro™ Anti-GDNF BBB Shuttle Protein (Cat#: NRZP-0423-ZP500)
- NeuroPro™ Anti-ASA BBB Shuttle Protein (Cat#: NRZP-0423-ZP504)